-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the morning of January 14, Zhendong Pharmaceutical announced that its wholly-owned subsidiary Anxin Bio had received the "Approval Notice for Supplementary Drug Application" issued by the State Drug Administration, and that Flunarizine Hydrochloride Capsules had been approved as a generic drug.
Flunarizine hydrochloride is a selective calcium antagonist, which can block excess calcium ions from transmembrane into cells, prevent excessive intracellular calcium load, and prevent a large amount of calcium from entering neurons during ischemia and hypoxia, improving brain microcirculation And neuron metabolism, inhibit cerebral vasospasm, platelet coagulation and blood viscosity increase, etc.
According to the data from Minet.
Flunarizine capsule companies passed the consistency evaluation, including Shandong Fangming Pharmaceutical Group Co.